Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
South Korea · Delayed Price · Currency is KRW 1,482.00
-11.00 (-0.74%)
At close: Nov 13, 2026
Kyung Nam Pharm Market Cap
Kyung Nam Pharm has a market cap or net worth of 29.08 billion as of November 13, 2026. It is the 36,026th most valuable company in the world and the 2,147th biggest in South Korea. Its market cap has decreased by 57.13% in one year.
Market Cap
29.08B
Enterprise Value
29.84B
Revenue
54.89B
Global Rank
Country Rank
#2,147 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 1, 2002, Kyung Nam Pharm's market cap has increased from 11.99B to 29.08B, an increase of 142.50%. That is a compound annual growth rate of 3.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 29.08B | -45.12% |
| Dec 30, 2025 | 52.98B | -15.36% |
| Dec 30, 2024 | 62.60B | 4.56% |
| Dec 28, 2023 | 59.87B | -27.59% |
| Dec 29, 2022 | 82.68B | -6.60% |
| Dec 30, 2021 | 88.52B | -37.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hwail Pharmaceutical | 44.00B |
| Jin Yang Pharmaceutical | 43.38B |
| GeneBioTech Co. ,Ltd | 43.23B |
| Eagle Veterinary Technology Co.,Ltd | 36.41B |
| Organoidsciences | 33.72B |
| Korean Drug | 30.55B |
| HLscience | 30.46B |
| Korea Arlico Pharm | 28.29B |